These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 2464708)

  • 1. [Treatment of ovarian cancer].
    Kato T; Nishimura H
    Gan No Rinsho; 1989 Jan; Spec No():392-8. PubMed ID: 2464708
    [No Abstract]   [Full Text] [Related]  

  • 2. [Advances in the comprehensive treatment of ovarian cancer].
    Yakushiji M; Sugiyama T
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1855-62. PubMed ID: 2454614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in CA125 concentration in ovarian cancer patients during the remission state--mean attenuating curve and the effectiveness of surgery and chemotherapy].
    Kawai M; Inagaki S; Yamashita H; Imaizumi H; Kakihara M; Arii Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):537-42. PubMed ID: 2474041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [VAB-3 chemotherapy of endodermal sinus tumor of the ovary].
    Goto Y; Imai K; Yamashita M; Konishi I; Fujii S; Noda Y; Okamura H; Mori T; Suzuki A
    Nihon Gan Chiryo Gakkai Shi; 1987 Feb; 22(1):75-80. PubMed ID: 2440967
    [No Abstract]   [Full Text] [Related]  

  • 5. [Carboplatin/epirubicin/prednimustine (Sterecyt) as an adjuvant chemotherapy combination in ovarian cancer treated by radical surgery].
    Pickel H
    Gynakol Rundsch; 1989; 29 Suppl 2():357-8. PubMed ID: 2693256
    [No Abstract]   [Full Text] [Related]  

  • 6. Current status of the second-look operation in ovarian cancer.
    Schwartz PE
    Clin Obstet Gynaecol; 1983 Aug; 10(2):245-59. PubMed ID: 6193920
    [No Abstract]   [Full Text] [Related]  

  • 7. [Significance of second look surgery in the therapy of ovarian cancer].
    Sasaki H; Ochiai K; Terashima Y
    Gan No Rinsho; 1990 Aug; 36(10):1174-8. PubMed ID: 2214157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisplatin, doxorubicin, and cyclophosphamide (PAC) in the treatment of mixed mesodermal tumor of the ovary.
    Wheelock J; Hancock K; Smith K
    Cancer Treat Rep; 1987 Dec; 71(12):1275-6. PubMed ID: 3690537
    [No Abstract]   [Full Text] [Related]  

  • 9. Stage IIIC small cell carcinoma of the ovary: survival with conservative surgery and chemotherapy.
    Rana S; Warren BK; Yamada SD
    Obstet Gynecol; 2004 May; 103(5 Pt 2):1120-3. PubMed ID: 15121630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of patients with ovarian carcinoma: experimental and clinical studies].
    Kikuchi Y; Kita T; Iwano I; Miyauchi M; Oomori K; Kizawa I; Kato K
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jul; 40(7):933-5. PubMed ID: 3418201
    [No Abstract]   [Full Text] [Related]  

  • 11. [Radical surgery for ovarian cancer].
    Ochiai K; Takakura S; Kawashima M
    Gan To Kagaku Ryoho; 1992 Oct; 19(12):1977-81. PubMed ID: 1417006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of chemo-immunotherapy of malignant ovarian tumors. Collaborated study with affiliated hospitals].
    Ota M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Aug; 37(8):1391-9. PubMed ID: 2995514
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of advanced epithelial ovarian cancer using cisplatin, adriamycin and cytoxan--the Indiana University experience.
    Ehrlich CE; Einhorn L; Stehman FB; Blessing J
    Clin Obstet Gynaecol; 1983 Aug; 10(2):325-35. PubMed ID: 6688562
    [No Abstract]   [Full Text] [Related]  

  • 14. Chemotherapy of advanced testicular cancer.
    Williams SD; Loehrer PJ; Einhorn LH
    Semin Urol; 1984 Nov; 2(4):230-7. PubMed ID: 6209762
    [No Abstract]   [Full Text] [Related]  

  • 15. [A combination of cyclophosphamide, adriamycin and platinum (CAP) in the treatment of stage III and IV ovarian cancer].
    Chylak V; Krusić J; Kolarić K
    Jugosl Ginekol Perinatol; 1988; 28(1-2):41-3. PubMed ID: 3398564
    [No Abstract]   [Full Text] [Related]  

  • 16. [Early diagnosis and effective treatment of ovarian cancer].
    Sawada M; Matsui Y; Okudaira Y
    Gan To Kagaku Ryoho; 1983 May; 10(5):1251-8. PubMed ID: 6191676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian cancer: what is poor prognosis disease?
    Cohen MH
    J Clin Oncol; 1990 Jul; 8(7):1287-8. PubMed ID: 2113572
    [No Abstract]   [Full Text] [Related]  

  • 18. Chemotherapy for ovarian adult granulosa cell tumour with synchronous endometrial adenocarcinoma.
    Ohara N; Teramoto K; Murao S
    J Obstet Gynaecol; 2002 Sep; 22(5):573-4. PubMed ID: 12521449
    [No Abstract]   [Full Text] [Related]  

  • 19. [Combined modality for recurrent and disseminated ovarian cancer--CAPF combination chemotherapy and second-look operation].
    Inagaki J; Ogawa M; Horikoshi N; Ezaki K; Inoue K; Aiba K; Komyo M; Miyamoto H; Ikeda K; Kubo H
    Gan No Rinsho; 1983 Aug; 29(10):1291-5. PubMed ID: 6685195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Preliminary evaluation of the effectiveness of a modified treatment program in patients with malignant testicular neoplasms].
    Madej G; Siedlecki P; Meyza J
    Pol Tyg Lek; 1987 Jul 6-7; 42(27-28):836-40. PubMed ID: 2446291
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.